A SINGLE CENTER REPORT OF THERAPEUTIC STRATEGIES IN PATIENTS WITH ATYPICAL CML (ACML) AND UNCLASSIFIED MDS/MPN (MDS/MPN-U)

被引：0
|
作者：
Braun, T. [1 ]
Debache, A. [1 ]
Roudot, H. [2 ]
Lusina, D. [2 ]
Thepot, S. [1 ]
Eclache, V. [2 ]
Martin, A. [3 ]
Soret, J. [1 ]
Brechignac, S. [1 ]
Kelaidi, C. [1 ]
Ades, L. [4 ]
Fenaux, P. [4 ]
Gardin, C. [1 ]
机构：
[1] Hop Avicenne, Hematol, F-93009 Bobigny, France
[2] Hop Avicenne, Lab Hematol, F-93009 Bobigny, France
[3] Hop Avicenne, Pathol, F-93009 Bobigny, France
[4] Hop St Louis, Hematol, Paris, France
来源：
LEUKEMIA RESEARCH | 2015年 / 39卷
关键词：
D O I：
10.1016/S0145-2126(15)30206-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
205
引用
收藏
页码：S102 / S102
页数：1
相关论文
共 39 条
  • [1] Therapeutic Strategies in Patients with Atypical CML (aCML) and Unclassified MDS/MPN (MDS/MPN-U). a Single Center Report
    Braun, Thorsten
    Debache, Aziza
    Roudot, Herve
    Lusina, Daniel
    Thepot, Sylvain
    Eclache, Virginie
    Martin, Antoine
    Soret, Juliette
    Harel, Stephanie
    Brechignac, Sabine
    Kelaidi, Charikleia
    Ades, Lionel
    Fenaux, Pierre
    Gardin, Claude
    BLOOD, 2014, 124 (21)
  • [2] A case of histoplasmosis in a patient with MDS/MPN-U
    Rastogi, Pulkit
    Sharma, Prashant
    Kumar, Narender
    Rudramurthy, Shivaprakash M.
    Varma, Neelam
    Varma, Subhash
    BLOOD RESEARCH, 2016, 51 (03) : 206 - 207
  • [3] A Multicenter Study of Atypical Chronic Myeloid Leukemia (aCML) and Myelodysplastic/Myeloproliferative Neoplasm-Unclassifiable (MDS/MPN-U)
    Wang, S. A.
    Hasserjian, R. P.
    Jesse, J.
    Weinzierl, E.
    Geyer, J. J.
    Chabot-Richards, D.
    Rogers, H. J.
    Hatem, J.
    Patel, K. P.
    Kanagal-Shamanna, R.
    Bagg, A.
    Hsi, E. D.
    Arber, D. D.
    Foucar, K.
    Luthra, R.
    Orazi, A.
    LABORATORY INVESTIGATION, 2014, 94 : 383A - 384A
  • [4] A Multicenter Study of Atypical Chronic Myeloid Leukemia (aCML) and Myelodysplastic/Myeloproliferative Neoplasm-Unclassifiable (MDS/MPN-U)
    Wang, S. A.
    Hasserjian, R. P.
    Jesse, J.
    Weinzierl, E.
    Geyer, J. J.
    Chabot-Richards, D.
    Rogers, H. J.
    Hatem, J.
    Patel, K. P.
    Kanagal-Shamanna, R.
    Bagg, A.
    Hsi, E. D.
    Arber, D. D.
    Foucar, K.
    Luthra, R.
    Orazi, A.
    MODERN PATHOLOGY, 2014, 27 : 383A - 384A
  • [5] Myelodysplastic/Myeloproliferative Neoplasms Unclassified (MDS/MPN-U) Overlap: Can We Alter the Natural History?
    Hendrix, Kaitlin
    Alali, Najla
    Padron, Eric
    Sallman, David
    List, Alan F.
    Lancet, Jeffrey E.
    Komrokji, Rami S.
    BLOOD, 2016, 128 (22)
  • [6] An Exercise in Extrapolation: Clinical Management of Atypical CML, MDS/MPN-Unclassifiable, and MDS/MPN-RS-T
    Talati, Chetasi
    Padron, Eric
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2016, 11 (06) : 425 - 433
  • [7] An Exercise in Extrapolation: Clinical Management of Atypical CML, MDS/MPN-Unclassifiable, and MDS/MPN-RS-T
    Chetasi Talati
    Eric Padron
    Current Hematologic Malignancy Reports, 2016, 11 : 425 - 433
  • [8] MYELODYSPLASTIC SYNDROME/MYELOPROLIFERATIVE NEOPLASM, UNCLASSIFIABLE (MDS/MPN-U), A SINGLE INSTITUTION EXPERIENCE
    Nyatanga, N.
    Kolitz, J.
    Akerman, M.
    Brody, J.
    Zhang, X.
    LEUKEMIA RESEARCH, 2015, 39 : S138 - S138
  • [9] Leukostasis as a result of rapidly progressive granulocytosis in a patient diagnosed with MDS/MPN-U
    Mykytiv, Vitaliy
    Alnajjar, Khalil
    BLOOD, 2019, 134 (23) : 2117 - 2117
  • [10] Molecular pathogenesis of atypical CML, CMML and MDS/MPN-unclassifiable
    Katerina Zoi
    Nicholas C. P. Cross
    International Journal of Hematology, 2015, 101 : 229 - 242
1234